
Reconstitution

Weight & Metabolism · 20mg
CAS 2381089-83-2
The Retatrutide 20mg vial (Reta, or the Reta peptide) is the larger format of the triple-agonist research peptide studied across the GLP-1, GIP, and glucagon receptor pathways at once. It holds double the material of the 10mg vial in a single lyophilised unit, which is why it is the format most researchers reach for when a longer investigation block would otherwise mean reordering. Same compound, same CAS reference (2381089-83-2), better per-milligram value.Retatrutide is studied in preclinical and in-vitro models for how simultaneous engagement of three metabolic receptors influences appetite signalling, glucose-handling models, and body-composition pathways. Reaching all three receptors is what distinguishes it from the single-agonist (GLP-1 only) and dual-agonist compounds that came before it, and it is that combined receptor profile, rather than any one pathway, that drives the current research interest.The 20mg format is the value choice for sustained work: the per-milligram cost is lower than buying two 10mg vials, and a single vial covers more reference aliquots before a reorder is needed. Researchers comparing receptor profiles across compounds may find our retatrutide versus tirzepatide library guide useful, and those wanting a smaller first reference batch can start with the Retatrutide 10mg vial.Every 20mg vial ships lyophilised with an independently verified batch certificate at a guaranteed floor of ≥98% purity, which you can confirm on the batch verification page using the batch number on the label. Reconstitute with bacteriostatic water: add it slowly down the wall of the vial, swirl to dissolve, and never shake. Store unopened at 2 to 8°C; refrigerate the reconstituted solution and do not refreeze it.Buying retatrutide in Australia is domestic and direct: free Australia Post Express shipping Australia-wide with no minimum spend, dispatch from within Australia within two business days of confirmed payment (most within 24 hours), and tracking on every parcel. Pay by card, PayPal, or PayID; every vial is sealed under argon with a 24-hour payment reservation on your stock. Supplied strictly as a research material for lawful laboratory and in-vitro use, not for human or veterinary consumption.
Retatrutide carries 175 indexed publications, 34 registered trials, 6 with Australian sites, 39,578 monthly readers on Wikipedia. Research activity sits at 73 papers in the past twelve months against 57 the year before.
High-intent searches for GLP-1, GIP, and glucagon-pathway research peptides.
175 papers, 73 this year · 34 trials, 6 in Australia · 39,578 readers (-29%) · S tier
Prepared with care, sealed under argon, and stored at 2–8°C until dispatch. Reconstitute with Bacteriostatic Water before use. Full preparation and storage guidance included with your order.
Independent third-party research on reptides.co — not affiliated with Polaris Research. Research reference only, not medical advice.
Retatrutide 20mg arrives sealed and research-ready, with a written preparation and storage card in every order. Prepare and store it as set out below, and use the reconstitution calculator to work out your concentration and draw volume before you begin.
Your Retatrutide 20mg vial arrives securely packaged. Refrigerate it sealed at 2–8°C until you are ready to prepare.
Add Bacteriostatic Water slowly against the vial wall, then swirl gently. Never shake.
Once prepared, aliquot and freeze at −20°C. Avoid repeated freeze–thaw cycles.
“The 20mg is the one to get on value. Immaculate vial, well cushioned, and dispatched faster than quoted.”
“Better value than buying two smaller vials and the same pristine packaging. Tracking was bang on.”
“Solid quality and quick dispatch. Would have liked the dispatch email a little sooner, but it landed on time.”
“Well packed, well sealed, and arrived two days after dispatch. Reordering without hesitation.”
“Exactly as described, discreet box, clear labelling, no fuss.”
Educational and product-logistics information only. Nothing here is medical advice or a therapeutic claim.
Research-grade retatrutide pricing per vial, per larger format, and per milligram, with a comparison to what a future pharmacy supply might look like.
Read →A single GLP-1 agonist next to a GLP-1, GIP, and glucagon triple agonist, and what the receptor reach means for research.
Read →Two of the most studied metabolic peptides compared, receptor targets, research context, and what the difference means in practice.
Read →Also Searched As·Retatrutide is also searched as Reta peptide, Reta, R3ta peptide, Reda peptide, Ratatouille peptide, Retatrude, Retatrutide peptide, Skinny jab, Triple G peptide.
Retatrutide appears in 175 indexed publications going back to 2022, including 73 in the past twelve months. 34 registered trials appear on ClinicalTrials.gov, 6 with Australian sites.
Publications per year. The final bar is the current year, still in progress.
| 2015 | 0 |
|---|---|
| 2016 | 0 |
| 2017 | 0 |
| 2018 | 0 |
| 2019 | 0 |
| 2020 | 0 |
| 2021 | 0 |
| 2022 | 2 |
| 2023 | 16 |
| 2024 | 41 |
| 2025 | 58 |
| 2026 | 58 |